Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
JNJ-47117096 is an inhibitor of maternal embryonic leucine zipper kinase (MELK; IC50 = 37 nM).1 It is selective for MELK over calcium/calmodulin-dependent protein kinase δ (CAMKIIδ), MAP kinase-interacting serine/threonine protein kinase 2 (MNK2), CAMKIIγ, and myosin light-chain kinase (MLCK; IC50s = 810, 760, 1,000, and 1,000 nM, respectively) but does inhibit FMS-related tyrosine kinase 3 (FLT3; IC50 = 18 nM). JNJ-47117096 inhibits autophosphorylation of MELK (IC50 = 0.52 µM) and proteasome-dependent degradation of MELK in MCF-7 cells.2 It induces cellular senescence and the DNA damage response mediated by ataxia-telangiectasia and Rad3-related protein kinase (ATM) in MCF-7 cells.
WARNING This product is not for human or veterinary use.
1. Fragment-
2. MELK-